26.10.2021
Replacment of IBOR-Rates
What are the legal restrictions on lenders introducing alternative rates?
News
-
-
20.10.2021Norway proposes to expand FDI filing obligation
On 11 October 2021, the Ministry of Justice, together with the Ministry of Defense, published a consultation paper on changes to the Security Act. The proposed changes include an expansion of the filing obligation to new categories of targets, a lowering of the investment thresholds that trigger filing, and the introduction of a notification deadline and a stand-still obligation.
-
15.10.2021New edition of Haavind’s Pharma Report
Welcome to the Autumn 2021 edition of Haavind’s Pharma Report. Pharma Report is a retrospective, report on legal developments in Norway relevant for the pharmaceutical sector, covering topics both within regulatory affairs and intellectual property. The report has been published twice a year since 2016.
-
08.10.2021Risk free interest rates
What happens in Norway with NIBOR, and what are the legal restrictions on banks introducing alternative rates?
Report
The Haavind Pharma Report 2020
In the Pharma Report Summer 2020, we take a retrospective look at some of the legal developments during the first half of 2020 in the Norwegian pharmaceutical sector.